jain.com

Cash SG&A guidance for September quarter

Company: IREN

Subject kind
guidance
Statement date
2026-08-31
Promised by
2026-09-30
Current status
outcome unconfirmed

What the later record shows

Outcome not yet confirmed

None of the passages report September-quarter 2026 results or actual cash SG&A, so whether the guided increase occurred cannot be determined.

Checked October 9, 2026 against filings, releases and reporting published after the claim was made. Quotes are verbatim from the linked documents.

The claim, verbatim

Cash SG&A is guided up another $40 to $50 million sequentially in the September quarter

Source (primary)

IREN Climbs 4% as Co-CEO Says Debt and Prepayments Can Fund FY27 Capex, TeraWulf Slips - Yahoo Finance (-, news_article)
View cached copy (2026-09-01)Live source ↗

Quote: “Cash SG&A is guided up another $40 to $50 million sequentially in the September quarter”

How we checked this

Checked on October 2, 2026. The cited source supports every part of this claim.

The article states that cash SG&A is guided up another $40 to $50 million sequentially in the September quarter, which matches the claim exactly.

Confirmed in the source:

What we did: Read our cached copy of the publisher (https://finance.yahoo.com/markets/stocks/articles/iren-climbs-4-co-ceo-174735195.html) in full (11,896 characters, retrieved September 1, 2026) and checked each assertion in the claim against it.

Additional evidence

confirms IREN Climbs 4% as Co-CEO Says Debt and Prepayments Can Fund FY27 Capex, TeraWulf Slips - Yahoo Finance

Quote: “Cash SG&A is guided up another $40 to $50 million sequentially in the September quarter”

View cached copy (2026-09-01)Live source ↗

Record of changes

September 1, 2026 — stated
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.
October 1, 2026 — outcome unconfirmed
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.